Dr. Mark Poznansky and colleagues look to the example set by Florence Nightingale and today’s women heads of state for intelligent, kind and practical leadership styles.
Photo: @Getty Images
Mark Poznansky MD, PhD, A Steve and Deborah Gorlin MGH Research Scholar, explains his approach to developing a vaccine for COVID-19
“The current COVID-19 pandemic has demonstrated how quickly an emerging infectious disease (EID) can spread across the globe, threaten individual heath and wreak havoc on the economy and our way of lives.
Almost a decade before the current COVID-19 outbreak, Mass General investigator and Infectious Diseases Physician, Mark Poznansky, MD, PhD, received funding from the Defense Advanced Research Projects Agency (DARPA) to develop a platform for accelerated vaccine development in the event of a rapidly spreading EID.
That forward-thinking funding resulted in…”
Mark Poznansky was interviewed by Alison Snyder of Axios and this article includes a number of his thoughts on how the virus is evolving and how vaccines must be able to react to these changes.
Augustin Vannier volunteers and helps prep the test kits’
Michael V. Callahan, MD is the Director, Clinical Translation & Mass-Casualty Therapeutics at VIC , an Infectious Disease Doctor at MGH and a special advisor to the US assistant secretary for preparedness and response.
This Wired piece The Dire Diplomacy of the Global ‘Race for a Vaccine’ by Brendan Borrell includes quotes from Dr. Callahan
Boston Globe Opinion piece by staff writer Felice J. Freyer on the concern of missed vaccinations for children
Following a press release on the article by FASEB Mark has been interviewed by a number of publications including Newsweek, The US News and the Daily Mail.
“There is no high-quality data showing that taking the anti-malarial drugs hydroxychloroquine and chloroquine can help COVID-19 patients, the authors of a review of existing evidence have warned. As such, they said the drugs should only be used to treat patients taking part in carefully designed clinical trials.”
When can we safely return to work and our normal way of life? How do we balance the health of people individually with the health of our nation economically?
Dr. Mark Poznansky helps us find the answer in a new opinion piece for The Hill.
Dr. Mark Poznansky was interviewed live on All in with Chris Hayes MSNBC, April 14 to discuss vaccines during the COVID-19 pandemic. Chris acknowledged that Dr. Poznansky is beginning research on a vaccine at the Vaccine and Immunotherapy Center at MGH and the discussion was based around the timeline for a vaccine and the efficacy of a vaccine before it can be used on millions of people worldwide. Dr. Poznansky also said that links with industry are crucial in order to move forward with efficacy studies and manufacturing after the initial vaccine design and noted that we are collaborating with Voltron, Inc and Hoth Therapeutics for this purpose.